Metabolic dysfunction-associated steatotic liver disease in adults

Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Reviewing MAESTRO-NASH and the implications for hepatology and health systems in implementation/accessibility of Resmetirom

Integrating social nutrition principles into the treatment of steatotic liver disease